Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Aim Vaccine, Astrazeneca, Aptamer, Astellas, Esperion, Hutchmed, Mesoblast, Santhera, Takeda, Tiumbio.